Trade Summary

5 days ago, Warren Eric, serving as Chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS), sold 7,438 shares at $26.87 per share, for a total transaction value of $199,885.09. Following this transaction, Warren Eric now holds 38,400 shares of MLYS.

This sale represents a 16.23% decrease in Warren Eric's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 21, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 23, 2026 at 6:39 PM ET, 2 days after the trade was made.

Mineralys Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.